Relative to the current CGF Annuity sales rate of ~4bnA$/year, 640mA$/year of new reinsurance from MS&AD is no small deal. Margins on this business will be conceivably lower, but the average duration is significantly longer than the one of the existing Annuity book. Makes sense to diversify away from A$-denominated annuities, while these are penalised by the negative yield differential vis-a-vis US$.
Ann: Challenger expands strategic relationship with MS&AD, page-2
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.15 |
Change
-0.100(1.60%) |
Mkt cap ! $4.252B | |||
| Open | High | Low | Value | Volume |
| $6.32 | $6.40 | $6.15 | $13.47M | 2.171M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9163 | $6.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.20 | 3624 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| CGF (ASX) Chart |